THE RELATIONSHIP OF INDICATORS OF ENDOTHELIAL FUNCTION AND MYOCARDIAL FIBROSIS WITH THE SEVERITY OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC HEART FAILURE WHO HAVE HAD A MYOCARDIAL INFARCTION

Highlights

• The severity of coronary atherosclerosis associated with a deterioration in the deformational properties of the myocardium, disturbances in microcirculation, as well as an increase in inflammatory and profibrotic biomarkers.

Abstract

Aim. To study the relationship between the severity of coronary atherosclerosis, endothelial dysfunction and myocardial fibrosis in patients with chronic heart failure who have had a myocardial infarction.

Methods. 96 patients with chronic heart failure hospitalized in the acute period of myocardial infarction were included. All participants underwent: echocardiographic examination with assessment of left ventricular ejection fraction (LVEF) and global longitudinal strain, laser doppler flowmetry, assessment of biomarker levels (CRP, sST2, NTproBNP, VEGF), coronary angiography.

Results. According to coronary angiography results, multivessel coronary artery disease was identified in 58 (60.4%) patients, and left main coronary artery (LMCA) involvement was found in 20 (20.8%). The severity of coronary atherosclerosis was associated with a decrease in LVEF (R = –0.31, p = 0.002), global longitudinal strain (R = –0.73, p < 0.001), amplitude-frequency parameters of microcirculation, volume of regulatory mechanisms, and coefficient of variation of microcirculation (R = –0.3, p = 0.003), as well as an increase in the degree of left ventricular diastolic dysfunction (R = 0.31, p = 0.002), capillary blood flow reserve (R = 0.29, p = 0.005), concentrations of CRP (R = 0.32, p = 0.002), NT-proBNP (R = 0.71, p < 0.001), and sST2 (R = 0.77, p < 0.001). Inverse relationships were identified between the number of affected coronary arteries and LVEF (R = –0.23; p = 0.027), coefficient of variation of microcirculation (R = –0.36, p < 0.001), and amplitude of microcirculation oscillations in the neurogenic range (R = –0.24, p = 0.019). Patients with LMCA stenosis had lower LVEF, amplitudes of oscillations in the neurogenic and myogenic ranges, as well as higher capillary blood flow reserve values.

Conclusion. The results of the study indicate a relationship between the severity of coronary atherosclerosis and changes in hemodynamics at the microcirculatory level, fibrotic remodeling of the myocardium, and concentrations of biomarkers such as CRP, NT-proBNP, and sST2.

1. Vaisman D.Sh., Enina E.N. Сoronary artery disease mortality rates in the Russian Federa-tion and a number of regions: dynamics and structure specifics. Cardiovascular Therapy and Pre-vention. 2024;23(7):3975 (In Russ.). https://doi.org/10.15829/1728-8800-2024-3975

2. Khan MA, Hashim MJ, Mustafa H, et al. Global Epidemiology of Ischemic Heart Dis-ease: Results from the Global Burden of Disease Study. Cureus. Published online July 23, 2020. doi:10.7759/cureus.9349

3. Hansson GK. Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med. 2005;352(16):1685-1695. doi:10.1056/NEJMra043430

4. Sitia S, Tomasoni L, Atzeni F, et al. From endothelial dysfunction to atherosclerosis. Au-toimmunity Reviews. 2010;9(12):830-834. doi:10.1016/j.autrev.2010.07.016

5. Neubauer K, Zieger B. Endothelial cells and coagulation. Cell Tissue Res. 2022;387(3):391-398. doi:10.1007/s00441- 021- 03471-2

6. Tsigkou V, Oikonomou E, Anastasiou A, et al. Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure. IJMS. 2023;24(5):4321. doi:10.3390/ijms24054321

7. Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in Heart Failure. Journal of the American College of Cardiology. 2020;75(11):1324-1340. doi:10.1016/j.jacc.2020.01.014

8. Vasan RS, Sullivan LM, Roubenoff R, et al. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study. Circulation. 2003;107(11):1486-1491. doi:10.1161/01.CIR.0000057810.48709.F6

9. Fish-Trotter H, Ferguson JF, Patel N, et al. Inflammation and Circulating Natriuretic Pep-tide Levels. Circ: Heart Failure. 2020;13(7):e006570. doi:10.1161/CIRCHEARTFAILURE.119.006570

10. Aimo A, Januzzi JL, Bayes-Genis A, et al. Clinical and Prognostic Significance of sST2 in Heart Failure. Journal of the American College of Cardiology. 2019;74(17):2193-2203. doi:10.1016/j.jacc.2019.08.1039

11. Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467.

12. Alexander Y, Osto E, Schmidt-Trucksäss A, et al. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Athero-sclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiol-ogy and Microcirculation, and Thrombosis. Cardiovascular Research. 2021;117(1):29-42. doi:10.1093/cvr/cvaa085

13. Sagaidachnyi A.A. Reactive hyperemia test: methods of analysis, mechanisms of reaction and prospects. Regional blood circulation and microcirculation. 2018;17(3):5-22 (In Russ.). https://doi.org/10.24884/1682-6655-2018-17-3-5-22

14. Hellmann M, Roustit M, Cracowski JL. Skin microvascular endothelial function as a bi-omarker in cardiovascular diseases? Pharmacological Reports. 2015;67(4):803-810. doi:10.1016/j.pharep.2015.05.008

15. Barbarash O.L., Duplyakov D.V., Zateischikov D.A., et al. 2020 Clinical practice guide-lines for Acute coronary syndrome without ST segment elevation. Russian Journal of Cardiology. 2021;26(4):4449. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4449

16. Russian Society of Cardiology. 2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.). https://doi.org/10.15829/29/1560-4071-2020-4103

17. Matsuzawa Y, Lerman A. Endothelial dysfunction and coronary artery disease: assess-ment, prognosis, and treatment. Coron Artery Dis. 2014;25(8):713-724. doi:10.1097/MCA.0000000000000178

18. Republican Specialized Scientific and Practical Medical Center of Cardiology, Fozilov KhG, Shek AB, et al. Features of left ventricular deformation properties in patients with coronary arteries. Clinical and Experimental Surgery. Petrovsky journal. 2021;9(3):118-124 (In Russ.). doi:10.33029/2308-1198-2021-9-3-118-124

19. Khomyakova D.A., Sayganov S.A., Grishkin Y.N. Features of left ventricle diastolic func-tion in patients with non q-wave myocardial infarction after percutaneous intervention // Herald of the Northwestern State Medical University named after I.I. Mechnikov. 2017; 9(2):44-50 (In Russ.)

20. Gutierrez E, Flammer AJ, Lerman LO, Elizaga J, Lerman A, Fernandez-Aviles F. Endo-thelial dysfunction over the course of coronary artery disease. European Heart Journal. 2013;34(41):3175-3181. doi:10.1093/eurheartj/eht351

21. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hy-peremia. Journal of the American College of Cardiology. 2004;44(11):2137-2141. doi:10.1016/j.jacc.2004.08.062

22. Selthofer-Relatić K, Stupin M, Drenjančević I, Bošnjak I. From Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) to Chronic Coronary Syndrome: Clinical Diagnostic Use of Laser Doppler Flowmetry in Coronary Microvascular Dysfunction. Am J Case Rep. 2020;21. doi:10.12659/AJCR.924984

23. Zhang J, Chen Z, Ma M, He Y. Soluble ST2 in coronary artery disease: Clinical bi-omarkers and treatment guidance. Front Cardiovasc Med. 2022;9:924461. doi:10.3389/fcvm.2022.924461

24. Miura-Takahashi E, Tsudome R, Suematsu Y, et al. An elevated level of soluble suppres-sion of tumorigenicity 2, but not galectin-3, is associated with the presence of coronary artery disease in hypertensive patients. Hypertens Res. 2025;48(2):650-661. doi:10.1038/s41440- 024- 01934-x

25. Hbaieb MA, Charfeddine S, Driss T, et al. Endothelial Dysfunction in Acute Myocardial Infarction: A Complex Association With Sleep Health, Traditional Cardiovascular Risk Factors and Prognostic Markers. Clinical Cardiology. 2025;48(1):e70080. doi:10.1002/clc.70080

26. Patti G, Pasceri V, Melfi R, et al. Impaired Flow-Mediated Dilation and Risk of Resteno-sis in Patients Undergoing Coronary Stent Implantation. Circulation. 2005;111(1):70-75. doi:10.1161/01.CIR.0000151308.06673.D2

27. Guazzi M, Reina G, Gripari P, Tumminello G, Vicenzi M, Arena R. Prognostic value of flow-mediated dilatation following myocardial infarction. International Journal of Cardiology. 2009;132(1):45-50. doi:10.1016/j.ijcard.2007.10.036

28.